Delivery Order SPE2DR25D1106-SPE2DR26FJD3P
- Not listed
- The Defense Logistics Agency awarded a $13,254.18 delivery order to AmerisourceBergen Drug Corp for PROMACTA 25 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This firm fixed price delivery order represents a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order...
- The Defense Logistics Agency awarded a $38,032.14 delivery order to AmerisourceBergen Drug Corp for PROMACTA 75 MG tablets (30-count units) under a firm fixed price contract, with performance scheduled for completion by January 2, 2026. This non-competitive, non-set-aside award leverages AmerisourceBergen's position as a critical pharmaceutical distributor within the federal medical supply chain. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,655.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROMACTA 12.5 MG tablets (30-count unit of use packaging) on December 2, 2025, with a completion date of December 23, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,418.06 to supply Promacta 25 mg tablets (30-count units) with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of PROMACTA 25 mg tablets in unit packs of 30 tablets. This is a firm fixed-price contract with a ceiling value of $4,418.06, featuring an award date of July 1, 2025, and an ultimate completion date of July 23, 2025. The award was competitively procured without a set-aside designation. AmerisourceBergen Drug Corp will perform this contract from its corporate office location in...
- The Defense Logistics Agency awarded a $17,672.24 delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on July 22, 2025, with a ceiling value of $24,059.26 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a $8,458.73 delivery order to AmerisourceBergen Drug Corp for 30-count units of Promacta 50 mg tablets, with an ultimate completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 10, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of PROMACTA 12.5 mg tablets in quantities of 30 units, with a contract ceiling value of $4,417.24 and an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,458.73 on December 9, 2025, for the supply of Promacta 50 mg tablets (30-count unit dose packages). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle that runs through December 2026. The delivery order will be fulfilled from the...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJD3PDelivery Order
The Defense Logistics Agency (DLA) awarded a $27,935.76 delivery order to AmerisourceBergen Drug Corp for PROMACTA 25 mg tablets (30-count units) with a completion date of January 5, 2026. This non-competitive, firm fixed-price delivery order was issued on December 11, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with DLA to supply critical pharmaceutical products to support federal medical procurement needs, particularly for military and veteran healthcare systems. AmerisourceBergen Drug Corp is one of the nation's largest pharmaceutical distributors and serves as a major supplier to DLA through its $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which runs through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order for PROMACTA, an immunosuppressive medication used to treat certain blood disorders, reflects the breadth of specialty pharmaceutical products distributed through this relationship to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 12/10/25 |